57 phenotypes from 13 alleles in 16 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Kdrorv/Kdrorv involves: 129S1/Sv * C57BL/6 * FVB/NJ	abnormal cranial neural crest cell migration	J:171522
	abnormal mandibular prominence morphology	J:171522
	abnormal nervous system development	J:171522
	abnormal second pharyngeal arch morphology	J:171522
	abnormal trigeminal ganglion morphology	J:171522
	abnormal vasculogenesis	J:171522
	absent fourth pharyngeal arch	J:171522
	absent third pharyngeal arch	J:171522
	decreased embryo size	J:171522
	embryonic lethality during organogenesis, complete penetrance	J:171522
	failure of chorioallantoic fusion	J:171522
	impaired cranial neural crest cell differentiation	J:171522
Kdrtm1.1Eia/Kdrtm1.1Eia B6.129P2-Kdrtm1.1Eia	abnormal vascular development	J:156869
	embryonic lethality, complete penetrance	J:156869
Kdrtm1.1Jamb/Kdrtm1.1Jamb involves: 129S1/Sv * 129X1/SvJ * ICR	abnormal lymphangiogenesis	J:154336
	increased susceptibility to injury	J:154336
	lymphatic vessel hyperplasia	J:154336
Kdrtm1.1Jamb/Kdrtm1.1Jamb Tg(KRT14-cre)1Efu/0 involves: 129S1/Sv * 129X1/SvJ * ICR	lymphatic vessel hyperplasia	J:154336
Kdrtm1.1Jamb/Kdrtm1.1Jamb Tg(Pax6-cre,GFP)1Pgr/0 involves: 129S1/Sv * 129X1/SvJ * FVB/N * ICR	abnormal basement membrane morphology	J:154336
	abnormal cornea morphology	J:154336
	abnormal lymphatic vessel morphology	J:154336
	lymphatic vessel hyperplasia	J:154336
Kdrtm1.1Msh/Kdrtm1.1Msh involves: 129P2/OlaHsd * C57BL/6J	absent organized vascular network	J:96124
	absent vitelline blood vessels	J:96124
	embryonic lethality during organogenesis, complete penetrance	J:96124
	impaired hematopoiesis	J:96124
Kdrtm1.1Vlcg/Kdrtm1.1Vlcg involves: 129S6/SvEvTac * C57BL/6NTac	no abnormal phenotype detected	J:200671
Kdrtm1.2Jamb/Kdrtm1.2Jamb involves: 129S1/Sv * 129X1/SvJ * ICR	abnormal embryo development	J:154336
Kdrtm1Eze/Kdrtm1Eze Tg(Prrx1-cre)1Cjt/0 involves: C57BL/6J * SJL/J	normal cardiovascular system phenotype	J:147285
Kdrtm1Jrt/Kdr+ involves: 129S1/Sv * 129X1/SvJ	no abnormal phenotype detected	J:26846
Kdrtm1Jrt/Kdr+ Tg(tetO-Kdr*)4377.5Rwng/0 Tg(Cebpb-tTA)5Bjd/0 involves: 129S1/Sv * 129X1/SvJ * FVB/N * NMRI	abnormal liver development	J:100427
Kdrtm1Jrt/Kdrtm1.1Jamb Tg(CAG-cre/Esr1*)1Egwa/0 involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2	abnormal induced retina neovascularization	J:173943
Kdrtm1Jrt/Kdrtm1.1Msh involves: 129P2/OlaHsd * B6.129-Kdrtm1Jrt/J * C57BL/6J	abnormal dorsal aorta morphology	J:96124
	abnormal extraembryonic mesoderm development	J:96124
	absent organized vascular network	J:96124
	absent visceral yolk sac blood islands	J:96124
Kdrtm1Jrt/Kdrtm1Jrt B6.129-Kdrtm1Jrt/J	abnormal dorsal aorta morphology	J:96124
	abnormal extraembryonic mesoderm development	J:96124
	absent organized vascular network	J:96124
	absent visceral yolk sac blood islands	J:96124
	absent vitelline blood vessels	J:96124
	impaired hematopoiesis	J:96124
Kdrtm1Jrt/Kdrtm1Jrt involves: 129S1/Sv * 129X1/SvJ	abnormal allantois morphology	J:125783
	abnormal definitive hematopoiesis	J:26846
	abnormal embryonic tissue morphology	J:26846
	absent organized vascular network	J:26846
	absent visceral yolk sac blood islands	J:26846
	absent vitelline blood vessels	J:26846
	congestive heart failure	J:26846
	decreased embryo size	J:26846
	embryo tissue necrosis	J:26846
	embryonic lethality during organogenesis, complete penetrance	J:26846
Kdrtm1Jrt/Kdrtm1Jrt Not Specified	absent organized vascular network	J:95387
Kdrtm1Jrt/Kdrtm2Sato Tg(Nes-cre)1Wmz/0 involves: 129S1/Sv * 129X1/SvJ	normal nervous system phenotype	J:175836
Kdrtm1Wag/Kdrtm1Wag Nfatc1tm1.1(cre)Bz/Nfatc1+ involves: 129S1/Sv * 129X1/SvJ * C57BL/6	abnormal angiogenesis	J:193198
	abnormal coronary artery morphology	J:193198
	abnormal interventricular septum morphology	J:193198
	decreased body size	J:193198
	heart hemorrhage	J:193198
	lethality throughout fetal growth and development, complete penetrance	J:193198
Kdrtm1Wag/Kdrtm1Wag Tg(Nes-cre)1Kln/0 involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL	normal behavior/neurological phenotype	J:86207
	normal nervous system phenotype	J:86207
Kdrtm2.1Jrt/Kdrtm2.1Jrt Tg(Cdh5-cre/ERT2)#Ykub/0 involves: 129S1/Sv * 129X1/SvJ	abnormal retina vasculature morphology	J:217533
	decreased total retina thickness	J:217533
	thin retina inner plexiform layer	J:217533
Kdrtm2.1Jrt/Kdrtm2.1Jrt Tg(Pax6-cre,GFP)2Pgr/0 involves: 129S1/Sv * 129X1/SvJ	abnormal retina vasculature morphology	J:217533
	persistence of hyaloid vascular system	J:217533
	normal vision/eye phenotype	J:217533
Kdrtm2.1Msh/Kdrtm2.1Msh involves: 129P2/OlaHsd * C57BL/6J	no abnormal phenotype detected	J:96124
Tg(tetO-Kdr*)4377.5Rwng/0 Tg(Cebpb-tTA)5Bjd/0 involves: FVB/N * NMRI	abnormal blood vessel morphology	J:100427
	abnormal hepatocyte morphology	J:100427
	abnormal liver morphology	J:100427
	abnormal liver physiology	J:100427
	normal homeostasis/metabolism phenotype	J:100427
	jaundice	J:100427
	normal liver/biliary system phenotype	J:100427
	perinatal lethality, incomplete penetrance	J:100427